Department of Pediatrics, Daejeon St. Mary's Hospital, The Catholic University of Korea, Daejeon, Republic of Korea.
Department of Pediatrics, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Virol J. 2022 Sep 6;19(1):141. doi: 10.1186/s12985-022-01875-2.
The development of the polymerase chain reaction (PCR) test promoted the evaluation of the epidemiological and clinical characteristics of human parainfluenza virus (HPIV) type 4, which has been rarely studied using conventional diagnostic methods. This study aimed to determine the seasonal epidemiological and clinical characteristics of all four HPIV serotypes (HPIV-1, HPIV-2, HPIV-3, and HPIV-4) during the era of PCR testing.
The medical records of hospitalized pediatric patients diagnosed with HPIV infections by a multiplex PCR test between 2015 and 2021 were retrospectively reviewed to determine the seasonal distributions of each HPIV serotype. For patients with a single HPIV infection, the clinical characteristics of each HPIV serotype were evaluated and compared with one another.
Among the 514 cases of HPIV infection, HPIV-1, HPIV-2, HPIV-3, and HPIV-4 were identified in 27.2%, 11.9%, 42.6%, and 18.3% of cases, respectively. HPIV-3 was most prevalent in spring, and the other three serotypes were most prevalent in autumn. For patients with a single HPIV infection, those infected by HPIV-1 and HPIV-3 were younger than those infected by HPIV-2 and HPIV-4 (P < 0.001). Croup and lower respiratory tract infection (LRI) were most frequently diagnosed in patients infected by HPIV-1 (P < 0.001) and HPIV-4 (P = 0.002), respectively. During 2020-2021, HPIV-3 was most prevalent in autumn and caused fewer LRIs (P = 0.009) and more seizures (P < 0.001) than during 2015-2019.
Each HPIV serotype exhibited a distinct seasonal predominance, and some differences in the clinical characteristics of the HPIV serotypes were observed. HPIV-4 acted as an important cause of LRI. Considering the recent changes in the epidemiological and clinical characteristics of HPIV-3, more time-series analyses should be conducted.
聚合酶链反应 (PCR) 检测技术的发展促进了人类副流感病毒(HPIV)4 型的流行病学和临床特征的评估,而使用传统诊断方法对其研究甚少。本研究旨在确定聚合酶链反应检测时代所有 4 种 HPIV 血清型(HPIV-1、HPIV-2、HPIV-3 和 HPIV-4)的季节性流行病学和临床特征。
回顾性分析 2015 年至 2021 年间经多重 PCR 检测诊断为 HPIV 感染的住院儿科患者的病历,以确定各 HPIV 血清型的季节性分布。对于单一 HPIV 感染的患者,评估并比较各 HPIV 血清型的临床特征。
在 514 例 HPIV 感染患者中,HPIV-1、HPIV-2、HPIV-3 和 HPIV-4 的检出率分别为 27.2%、11.9%、42.6%和 18.3%。HPIV-3 最常见于春季,其他三种血清型最常见于秋季。对于单一 HPIV 感染的患者,感染 HPIV-1 和 HPIV-3 的患者比感染 HPIV-2 和 HPIV-4 的患者年龄更小(P<0.001)。感染 HPIV-1(P<0.001)和 HPIV-4(P=0.002)的患者最常被诊断为哮吼和下呼吸道感染(LRI)。2020-2021 年,HPIV-3 秋季流行,导致的 LRI 较少(P=0.009),癫痫发作较多(P<0.001),而 2015-2019 年流行的 HPIV-3 则较少。
各 HPIV 血清型表现出明显的季节性优势,且观察到各 HPIV 血清型的临床特征存在一些差异。HPIV-4 是 LRI 的重要原因。考虑到 HPIV-3 近期的流行病学和临床特征变化,应进行更多的时间序列分析。